PIGA, ISABELLA
 Distribuzione geografica
Continente #
NA - Nord America 8.828
AS - Asia 6.351
EU - Europa 5.532
SA - Sud America 905
AF - Africa 151
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 21.787
Nazione #
US - Stati Uniti d'America 8.245
IT - Italia 2.046
SG - Singapore 1.885
CN - Cina 1.324
VN - Vietnam 1.231
HK - Hong Kong 839
DE - Germania 705
BR - Brasile 681
RU - Federazione Russa 638
IE - Irlanda 520
CA - Canada 477
SE - Svezia 455
GB - Regno Unito 281
IN - India 200
FR - Francia 194
BD - Bangladesh 187
AT - Austria 129
KR - Corea 106
UA - Ucraina 105
ID - Indonesia 102
FI - Finlandia 94
AR - Argentina 81
NL - Olanda 76
ES - Italia 67
JP - Giappone 65
MX - Messico 59
PL - Polonia 59
TR - Turchia 58
ZA - Sudafrica 58
IQ - Iraq 55
DK - Danimarca 40
PH - Filippine 39
PK - Pakistan 38
EC - Ecuador 33
SA - Arabia Saudita 32
CO - Colombia 29
CH - Svizzera 24
MA - Marocco 24
LT - Lituania 22
VE - Venezuela 22
PY - Paraguay 21
MY - Malesia 20
AU - Australia 18
BE - Belgio 17
IR - Iran 17
TW - Taiwan 17
UZ - Uzbekistan 17
EG - Egitto 12
KE - Kenya 12
LB - Libano 12
OM - Oman 12
TN - Tunisia 12
UY - Uruguay 12
CL - Cile 11
IL - Israele 11
TH - Thailandia 11
ET - Etiopia 9
KZ - Kazakistan 9
PE - Perù 9
CR - Costa Rica 8
CZ - Repubblica Ceca 8
JO - Giordania 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
JM - Giamaica 7
BO - Bolivia 6
DZ - Algeria 6
SY - Repubblica araba siriana 6
AL - Albania 5
BG - Bulgaria 5
KG - Kirghizistan 5
LV - Lettonia 5
NP - Nepal 5
PA - Panama 5
PS - Palestinian Territory 5
PT - Portogallo 5
RO - Romania 5
GR - Grecia 4
HN - Honduras 4
KW - Kuwait 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AM - Armenia 3
GA - Gabon 3
GT - Guatemala 3
HR - Croazia 3
SV - El Salvador 3
BH - Bahrain 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GE - Georgia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MN - Mongolia 2
MT - Malta 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
Totale 21.758
Città #
Ann Arbor 1.300
Singapore 1.100
Milan 818
Hong Kong 807
Ashburn 795
San Jose 704
Dublin 508
Frankfurt am Main 493
Chandler 458
Toronto 352
Fairfield 351
Ho Chi Minh City 330
Wilmington 311
Hanoi 301
New York 271
Dallas 217
Los Angeles 217
Santa Clara 217
Dearborn 208
Beijing 177
Woodbridge 157
Seattle 148
Chicago 143
Houston 142
Cambridge 139
Princeton 135
The Dalles 129
Hefei 126
Shanghai 123
Dong Ket 116
Seoul 98
Rome 87
Vienna 87
São Paulo 82
Lauterbourg 77
Nanjing 73
Council Bluffs 70
Moscow 67
Jakarta 65
Helsinki 57
Buffalo 56
Orem 56
Montreal 50
Kent 48
Munich 48
Jacksonville 47
Tokyo 47
Da Nang 46
London 44
Nuremberg 43
Warsaw 41
Brooklyn 40
Boardman 39
Denver 39
Chennai 35
Guangzhou 32
Turin 32
Cagliari 28
Haiphong 28
Lawrence 28
Nanchang 28
Hải Dương 27
Altamura 26
Amsterdam 26
Changsha 26
Florence 26
Madison 26
Poplar 26
Caronno Pertusella 25
Shenyang 25
Basingstoke 24
Fremont 24
Lissone 23
Columbus 22
Johannesburg 22
Ottawa 22
Ha Long 21
Manchester 21
Washington 21
Baghdad 20
Hebei 20
Rio de Janeiro 20
Zhengzhou 20
Atlanta 19
Mumbai 19
Phoenix 19
San Diego 19
San Francisco 19
Stockholm 19
Tianjin 19
Biên Hòa 18
Jinan 18
Lappeenranta 18
Andover 17
Cinisello Balsamo 17
Naples 17
Pavia 17
Quận Bình Thạnh 17
Bologna 16
Tashkent 16
Totale 13.728
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 593
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 560
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 541
Cytological Cytospin Preparation for the Spatial Proteomics Analysis of Thyroid Nodules Using MALDI-MSI 468
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 458
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 451
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 423
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 402
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 380
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 372
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 372
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 371
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 364
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 360
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 357
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 357
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 356
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 331
Unsupervised neural networks as a support tool for pathology diagnosis in MALDI-MSI experiments: A case study on thyroid biopsies 317
The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations 317
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 317
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 303
A molecular imaging approach to individuate tumour infiltrating lymphocytes 289
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 276
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 274
Mapping the distribution of bioactive compounds and aroma/flavour precursors in green coffee beans with an integrated mass spectrometry-based approach 273
Exploring 6-aza-2-Thiothymine as a MALDI-MSI Matrix for Spatial Lipidomics of Formalin-Fixed Paraffin-Embedded Clinical Samples 272
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 272
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 265
Proteomics tools and mass spectometry imaging techiques for the molecular characterization of pancreas 264
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 262
Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing 253
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 252
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 252
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 250
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 243
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 243
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 241
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 237
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 235
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 235
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 234
Putative salivary biomarkers useful to differentiate patients with fibromyalgia 227
Total and synaptoproteomic changes underlying response/non-response to the rapid antidepressant effect of ketamine in the hippocampus of a preclinical model of depression. 226
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 215
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 214
Ultra-high resolution MALDI-FTICR-MSI analysis of intact proteins in mouse and human pancreas tissue 211
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 200
The management of haemoglobin interference for the MALDI-MSI analysis of in-vivo thyroid biopsies 193
Ultra-high resolution MALDI-FTICR-MSI analysis of intact proteins in mouse and human pancreas tissue 192
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 190
Glucagon-like peptide 1 protects INS-1E mitochondria against palmitate-mediated beta-cell dysfunction: A proteomic study 188
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 186
Data analysis optimisation of a DIA-PASEF mass spectrometry approach for the study of idiopathic membranous nephropathy disease 185
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 184
Influence of sampling on the determination of warfarin and warfarin alcohols in oral fluid 183
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 182
MALDI-MSI as complementary tool in the characterization of thyroid nodules: novelties and challenges in the evolving landscape of diagnostic pathology 180
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 177
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 175
Recent advances in MALDI mass spectrometry imaging: a cutting edge tool for the diagnosis of thyroid nodules 174
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 171
Machine Learning Ensemble Algorithms for Classification of Thyroid Nodules Through Proteomics: Extending the Method of Shapley Values from Binary to Multi-Class Tasks 170
C0513: A Non-Invasive Approach for Monitoring Patients Undergoing Anticoagulant Therapy 170
Determination of total and unbound warfarin and warfarin alcohols in human plasma by high performance liquid chromatography with fluorescence detection 168
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 168
Biomarker identification through spatial proteomics for the characterization of indeterminate thyroid nodules 167
Does the urinary proteome reflect ccrcc stage and grade progression? 164
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 161
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 157
High resolution MALDI-FTICR-MSI analysis of intact proteins in mouse pancreas tissue 155
Determination of anticoagulant drugs and their metabolites in oral fluid: strategies for sample collection 154
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 150
Advances in thyroglobulin measurement: exploring dried blood spot sampling and mass spectrometry for enhanced clinical utility 148
Influence of sampling on the measured concentration of Warfarin and Warfarin alcohols in oral fluid 148
Determination of Warfarin and Warfarin alcohols in oral fluid and plasma samples for monitoring patients undergoing anticoagulant therapy 147
High resolution MALDI-FTICR-MSI analysis of intact proteins in mouse pancreas tissue 147
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 147
Comparative proteomics of native tuscany cultivars of olea europaea: a preliminary study 146
Determination of Warfarin and Warfarin alcohols in saliva and plasma by high performance liquid chromatography with fluorimetric detection 145
Development of mass spectrometry imaging methods for the analysis of intact proteins in mouse pancreas tissues by MALDI-TOF-MS and MALDI-FTICR-MS 144
MALDI-MS Imaging Application in Thyroid FNA: Challenges and Perspectives 142
Elaborazione dei dati analitici: valutazione della qualità e costruzione di immagini molecolari 141
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 139
Determination of anticoagulant drugs and their metabolites in oral fluid and plasma samples by HPLC-Fluorimetry 138
Monitoring of warfarin therapy: Preliminary results from a longitudinal pilot study 135
Glucagon-like peptide-1 protects INS-1E against palmitatemediated β-cell dysfunction: a proteomic study 134
New insights in MSI pathology: a molecular snapshot of thyroid cancer 130
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 128
Elaborazione dei dati analitici: valutazione della qualità e costruzione di immagini molecolari 115
6-Aza-2-Thiothymine as a Novel Matrix for MALDI-MSI-Based Lipid Profiling in FFPE Samples 105
Recent Advances in MALDI Mass Spectrometry Imaging: A Cutting-Edge Tool for the Diagnosis of Thyroid Nodules 93
Functional, synaptoproteomic and structural adaptations underlying sex-dependent traumatic stress susceptibility/resilience in the hippocampus 84
Elaboration Pipeline for the Management of MALDI-MS Imaging Datasets 82
Well Begun Is Half Done: The Impact of Pre-Processing in MALDI Mass Spectrometry Imaging Analysis Applied to a Case Study of Thyroid Nodules 79
Advances in thyroglobulin measurement: exploring dried blood spot mass spectrometry for enhanced clinical utility 42
Using an integrated omics approach to uncover the mechanisms underlying chemotherapy-induced peripheral neuropathy (CIPN) 27
Boosting thyroid nodule diagnosis through ultrasound and molecular imaging integration with unsupervised learning 27
Advancing Thyroid Nodule Diagnosis: Integrating MALDI-MSI for Detailed Characterization of Indeterminate Lesions 8
A novel application of ATT as a MALDI MS matrix for the imaging of tryptic peptides 7
Totale 22.457
Categoria #
all - tutte 68.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.610


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021249 0 0 0 0 0 0 0 0 0 0 0 249
2021/20221.078 96 98 59 128 60 91 9 60 44 95 115 223
2022/20231.981 219 504 220 162 96 271 21 129 165 34 88 72
2023/20241.632 52 53 78 114 165 447 325 46 130 26 58 138
2024/20253.411 152 277 226 165 278 140 202 95 412 599 308 557
2025/202610.167 1.190 632 757 1.188 1.048 473 1.459 445 728 796 641 810
Totale 22.457